Comparative study to assess ecacy and safety of brinzolamide 1% and timolol 0.5% fixed combination eye drops versus dorzolamide 2% and timolol 0.5% fixed combination eye drops in management of open-angle glaucoma
Indicated in the treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or pseudoexfoliative glaucoma when topical beta-blocker monotherapy is not sufficient.
Dorzolamide/Timolol 20 mg/ml + 5 mg/ml, Preservative-Free, Eye drops, solution in single-dose containeris indicated in the treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or pseudoexfoliative glaucoma when topical beta-blocker monotherapy is not sufficient.
Dorzolamide/Timolol is indicated in the treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or pseudo-exfoliative glaucoma when topical beta-blocker monotherapy is not sufficient.